MLEC
Moolec Science SA
NASDAQ · Healthcare · Biotechnology · LU
$6.10
−2.09%Latest reported
- Last report date
- Oct 1, 2025
- EPS actual
- -$0.70
- EPS estimate
- -$0.70
- Revenue actual
- —
- Revenue estimate
- $2.0M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 1
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- -7446.4%
- Revenue beats (12Q)
- 2
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Oct 1, 2025 | -$0.70 | -$0.70 | In line | — |
| Apr 16, 2025 | -$0.06 | -$9.00 | Miss -14900.00% | — |
| Oct 2, 2024 | -$0.07 | -$10 | Miss -14885.71% | $1.6M |
| Jun 30, 2024 | — | -$1.05 | — | $1.5M |
| Mar 13, 2024 | -$7.50 | -$7.50 | In line | $252.1K |
| Dec 14, 2023 | -$7.50 | -$6.00 | Beat 20.00% | $1.7M |
| Jul 10, 2023 | — | -$0.14 | — | — |
| Jun 30, 2023 | — | -$1.10 | — | $905.0K |
| Dec 31, 2022 | — | -$19 | — | — |
| Sep 30, 2022 | — | -$0.24 | — | — |
| Jun 30, 2022 | — | -$0.61 | — | — |
| Mar 31, 2022 | — | -$0.47 | — | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Apr 14, 2026